Silk fibroin is a protein-based natural polymer. Due to its excellent mechanical properties, good biocompatibility and bioabsorbability, silk fibroin has always been a hot topic in biomedical materials and is widely used in tissue repair and regeneration, artificial organs, drug delivery. As a bioregenerative material, silk fibroin has low immunogenicity, can adhere to cells and guide growth. It can induce the production of autologous soft tissue and can eventually be completely degraded. The degradation time can also be controlled. It is also an ideal medical and aesthetic material.

The global Silk Fibroin Biomaterials market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime 's newest research report, the “Silk Fibroin Biomaterials Industry Forecast” looks at past sales and reviews total world Silk Fibroin Biomaterials sales in 2023, providing a comprehensive analysis by region and market sector of projected Silk Fibroin Biomaterials sales for 2024 through 2030. With Silk Fibroin Biomaterials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Silk Fibroin Biomaterials industry.

This Insight Report provides a comprehensive analysis of the global Silk Fibroin Biomaterials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Silk Fibroin Biomaterials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Silk Fibroin Biomaterials market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Silk Fibroin Biomaterials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Silk Fibroin Biomaterials.

United States market for Silk Fibroin Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Silk Fibroin Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Silk Fibroin Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Silk Fibroin Biomaterials players cover:

• Sofregen Inc
• Evolved By Nature
• Cocoon Biotech
• CPT Sutures
• Kelisema Srl

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Silk Fibroin Biomaterials market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Medical Grade Raw Materials
• Cosmetic Grade Raw Materials
• Others

Segmentation by Application:

• Bone Nail Plate
• Artificial Cartilage
• Biomedicine (Film Dressings, Drug Carriers)
• Cosmetic
• Food Preservation
• Fabric
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration:

• Sofregen Inc
• Evolved By Nature
• Cocoon Biotech
• CPT Sutures
• Kelisema Srl
• Seidecos
• SEIREN Co., Ltd.
• DSM
• Croda
• Jiangxi Silk Biotechnology Co., Ltd.
• Simatech Incorporation
• Zhejiang Xingyue Biotechnology Co., Ltd.
• Hubei Sailuo Biomaterials Co., Ltd.
• Favorsun
• Chinatiansi
• Hangzhou Lin Ran Bio-tech Co.,Ltd
• Haifan
• Cathaya
• Suhaobio

Key Questions Addressed in this Report

1. What is the 10-year outlook for the global Silk Fibroin Biomaterials market?
2. What factors are driving Silk Fibroin Biomaterials market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Silk Fibroin Biomaterials market opportunities vary by end market size?
5. How does Silk Fibroin Biomaterials break out by Type, by Application?